CareDx (CDNA) announced that Keith Kennedy, the company’s COO, will also assume the responsibilities of CFO and oversee the company’s finance organization effective February 26. Kennedy has served as COO since September 2024. Nathan Smith announced on the company’s quarterly earnings call that he will be stepping down from his role as CFO.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDNA:
- CareDx Names New CFO Amid Strong Q4 2025 Results
- CareDx reports Q4 adjusted EPS 12c, consensus 23c
- CareDx sees FY26 revenue $420M-$440M, consensus $417.67M
- CDNA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- CareDx: Solid Near-Term Beat but LCD Overhang and Reimbursement Uncertainty Justify Hold Rating